The aim was to systematically review genetic testing guidelines in the evaluation of children with autism spectrum disorders (ASDs). The Clinical Report published by the American Academy of Pediatrics (AAP)1 recommended individualizing the workup, including karyotype and specific DNA testing for fragile X syndrome. A recent publication reported higher rates of abnormalities on CGH microarray (CMA) testing on children with ASD.2 The medical records of 507 children seen through the Kirch Developmental Services Center were abstracted for genetic testing and factors associated with this testing. Abnormalities were found on karyotype in 2.3% and in DNA for fragile X in 0.04%. The author concludes that the diagnostic yield of the genetic testing was low in this population. Furthermore, their findings support the theory that CMA can be considered as part of the initial genetic screening in children with ASD in most situations. Future studies will need to be done prospectively to evaluate children in a standard fashion.
Kogan MD, Blumberg SJ, Schieve LAPrevalence of parent-reported diagnosis of autism spectrum disorder among children in the US, 2007. Pediatrics. 2009;124:1395-1403.
2.
Fombonne E., Chakrabarti S.No evidence for a new variant of measles-mumps-rubella-induced autism. Pediatrics. 2001;108:E58.
3.
Autism and Developmental Disabilities Monitoring Network Surveillance Year 2006 Principal Investigators; Centers for Disease Control and Prevention (CDC).Prevalence of autism spectrum disorders: Autism and Developmental Disabilities Monitoring Network, United States, 2006. MMWR Surveill Summ. 2009;58:1-20.
4.
Voigt RG, Dickerson CL, Reynolds AM, Childers DO, Rodriguez DL, Brown FRLaboratory evaluation of children with autistic spectrum disorders: a guide for primary care pediatricians. Clin Pediatr ( Phila). 2000;39:669-671.
5.
Battaglia A. , Carey JCEtiologic yield of autistic spectrum disorders: a prospective study. Am J Med Genet C Semin Med Genet. 2006;142:3-7.
6.
Herman GE, Henninger N., Ratliff-Schaub K., Pastore M., Fitzgerald S., McBride KLGenetic testing in autism: how much is enough?Genet Med. 2007;9:268-274.
7.
Selkirk CG, McCarthy Veach P., Lian F., Schimmenti L., LeRoy BSParents’ perceptions of autism spectrum disorder etiology and recurrence risk and effects of their perceptions on family planning: recommendations for genetic counselors. J Genet Couns. 2009 ;18:507-519.
8.
Harrington JW , Patrick PA, Edwards KS, Brand DAParental beliefs about autism: implications for the treating physician. Autism. 2006;10:452-462.
9.
Fombonne E., Du Mazaubrun C., Cans C., Grandjean H.Autism and associated medical disorders in a French epidemiological survey . J Am Acad Child Adolesc Psychiatry. 1997 ;36:1561-1569.
10.
Kielinen M., Rantala H., Timonen E., Linna SL, Moilanen I.Associated medical disorders and disabilities in children with autistic disorder: a population-based study. Autism. 2004;8:49-60.
11.
Chakrabarti S. , Fombonne E.Pervasive developmental disorders in preschool children. JAMA. 2001;285:3093-3099.
12.
Abdul-Rahman OA, Hudgins L.The diagnostic utility of a genetics evaluation in children with pervasive developmental disorders. Genet Med. 2006;8:50-54.
13.
Schaefer GB , Lutz REDiagnostic yield in the clinical genetic evaluation of autism spectrum disorders. Genet Med. 2006 ;8:549-556.
14.
Shen Y., Dies KA, Holm IA, Bridgemohan C.Clinical genetic testing for patients with autism spectrum disorders. Pediatrics. 2010;125:e727-e735.
15.
Johnson CP, Myers SMIdentification and evaluation of children with autism spectrum disorders. Pediatrics. 2007;120:1183-1215.
16.
Miller DTGenetic testing for autism: recent advances and clinical implications. Expert Rev Mol Diagn. 2010;10: 837-840.
17.
writer staff .Uninsured rates lowest in NY State. Democrat and Chronicle. 2010; 4B.
18.
Lord C., Risi S., Lambrecht L., et al. Autism diagnostic observation schedule: a standardized observation of communicative and social behavior. J Autism Dev Disord . 1989;19:185-212.
19.
Norris M., Lecavalier L.Screening accuracy of Level 2 autism spectrum disorder rating scales: a review of selected instruments. Autism. 2010;14:263-284.
20.
Charman T., Baird G., Simonoff E., et al. Efficacy of three screening instruments in the identification of autistic-spectrum disorders. Br J Psychiatry. 2007;191:554-559.
21.
Gillberg C. , Cederlund M., Lamberg K., Zeijlon L.Brief report: "the autism epidemic." The registered prevalence of autism in a Swedish urban area. J Autism Dev Disord. 2006;36:429-435.
22.
Bailey A., Bolton P., Butler L., et al. Prevalence of the fragile X anomaly amongst autistic twins and singletons. J Child Psychol Psychiatry. 1993 ;34:673-688.
23.
Freitag CM, Staal W., Klauck SM, Duketis E., Waltes R.Genetics of autistic disorders: review and clinical implications. Eur Child Adolesc Psychiatry. 2010;19: 169-178.
24.
Autism Treatment Network. http://www.autismspeaks.org/science/programs/atn/index.php. Accessed December 20, 2010 .
25.
Barton M., Volkmar F.How commonly are known medical conditions associated with autism? J Autism Dev Disord. 1998;28:273-278.
26.
Challman TD , Barbaresi WJ, Katusic SK, Weaver A.The yield of the medical evaluation of children with pervasive developmental disorders. J Autism Dev Disord . 2003;33:187-192.
27.
Kosinovsky B., Hermon S., Yoran-Hegesh R., et al. The yield of laboratory investigations in children with infantile autism. J Neural Transm. 2005;112:587-596.
